Skip to main content

LU K73 Pill - yellow capsule/oblong, 17mm

Pill with imprint LU K73 is Yellow, Capsule/Oblong and has been identified as Quetiapine Fumarate Extended-Release 200 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Quetiapine is used in the treatment of Bipolar Disorder; Schizoaffective Disorder; Schizophrenia; Depression; Major Depressive Disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LU K73

Quetiapine Fumarate Extended-Release

Imprint
LU K73
Strength
200 mg
Color
Yellow
Size
17.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC)
68180-0614
Inactive Ingredients
microcrystalline cellulose, ferric oxide yellow, hypromellose 2208 (15000 mPa.s), hypromellose 2910 (15000 mPa.s), hypromelloses, lactose monohydrate, magnesium stearate, polyethylene glycol 400, titanium dioxide, trisodium citrate dihydrate

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer